(Q39343347)

11 September 2017

title

Dextran-catechin conjugate: a potential treatment against the pancreatic ductal adenocarcinoma (English)

1 reference

11 September 2017

1 reference

Niccola Funel

8

0 references

Ortensia I. Parisi

Ortensia Ilaria Parisi

9

0 references

Francesco Puoci

Francesco Puoci

10

0 references

Francesca Iemma

Francesca Iemma

3

0 references

Giuseppe Cirillo

Giuseppe Cirillo

2

0 references

Nevio Picci

Nevio Picci

11

0 references

Emanuela Jacchetti

5

Emanuela Jacchetti

1 reference

11 September 2017

Orazio Vittorio

1

1 reference

11 September 2017

Giovanni Di Turi

4

1 reference

11 September 2017

Michele Curcio

6

1 reference

11 September 2017

Serena Barbuti

7

1 reference

11 September 2017

publication date

24 May 2012

1 reference

11 September 2017

published in

Pharmaceutical Research

1 reference

11 September 2017

volume

29

1 reference

11 September 2017

issue

9

1 reference

11 September 2017

page(s)

2601-2614

1 reference

11 September 2017

cites work

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0790-9

A Case-Control Study of Diet and Cancer of the Pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0790-9

A meta-analysis of obesity and the risk of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0790-9

Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0790-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0790-9

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0790-9

New applications of gemcitabine and future directions in the management of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0790-9

Gemcitabine: progress in the treatment of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0790-9

Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0790-9

EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0790-9

Inhibition of anti-apoptotic Bcl-2 family proteins by natural polyphenols: new avenues for cancer chemoprevention and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0790-9

Polymer conjugates as anticancer nanomedicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0790-9

Polymer conjugates: nanosized medicines for treating cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0790-9

Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0790-9

Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0790-9

HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0790-9

A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0790-9

Synthesis of antioxidant polymers by grafting of gallic acid and catechin on gelatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0790-9

Biological activity of a gallic acid-gelatin conjugate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0790-9

Targeted drug conjugates: principles and progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0790-9

Development and characterization of gemcitabine-resistant pancreatic tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0790-9

Stabilization of pharmaceuticals to oxidative degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0790-9

Immortalization with telomerase of the Nestin-positive cells of the human pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0790-9

Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0790-9

Mitochondrial localization of reactive oxygen species by dihydrofluorescein probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0790-9

Peroxidase-catalyzed oxidative polymerization of bisphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0790-9

The effect of micro and nanotopography on endocytosis in drug and gene delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0790-9

Starch-quercetin conjugate by radical grafting: synthesis and biological characterization.

21 January 2018

1 reference

12 December 2020

Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression

1 reference

12 December 2020

Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee

1 reference

12 December 2020

A phase II trial of gemcitabine in combination with 5-fluorouracil (24-hour) and folinic acid in patients with chemonaive advanced pancreatic cancer

1 reference

12 December 2020

Molecular pathways supporting the proliferation staging of malignant melanoma (review).

1 reference

12 December 2020

Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins.

1 reference

12 December 2020

Gemcitabine and protracted 5-FU for advanced pancreatic cancer. A phase II study

1 reference

12 December 2020

Poly-L-arginine and dextran sulfate-based nanocomplex for epidermal growth factor receptor (EGFR) siRNA delivery: its application for head and neck cancer treatment

1 reference

12 December 2020

Tea and tea polyphenols in cancer prevention

1 reference

12 December 2020

10.1007/S11095-012-0790-9

Identifiers

DOI

1 reference

11 September 2017

1 reference